Physician profile
Olson Parrott
NPI 1922050491
$2,598.13
in general payments reported to CMS, 2019-2025
35 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $133 · 2021: $317 · 2022: $526 · 2023: $586 · 2024: $442 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,360.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $324.56 | 2022-2024 | Ova1 |
| Abbvie INC. | $287.07 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $182.68 | 2019-2025 | |
| Astellas Pharma US INC | $182.23 | 2019-2025 | Veozah, Myrbetriq |
| Shield Therapeutics INC | $177.33 | 2023-2025 | |
| Pfizer INC. | $122.09 | 2019-2024 | |
| Exeltis, USA INC. | $110.26 | 2021-2025 | Slynd |
| Biogen, INC. | $107.96 | 2024 | Zurzuvae |
| Novo Nordisk INC | $96.42 | 2022 | |
| Avion Pharmaceuticals | $90.26 | 2019-2021 | |
| Channel Medsystems, INC. | $86.56 | 2023-2024 | |
| Hologic Sales and Service, LLC | $84.65 | 2019-2024 | Aptima, Acessa Provu System |
| Sage Therapeutics, LLC | $78.46 | 2023-2025 | Zurzuvae |
| Agile Therapeutics, INC. | $78.14 | 2021-2022 | |
| Organon LLC | $67.62 | 2021-2025 | Nexplanon |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $60.41 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Mylan Pharmaceuticals INC. | $59.08 | 2021 | |
| Mayne Pharma Commercial LLC | $57.42 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $52.51 | 2023-2025 | Myfembree |
| Coopersurgical, INC. | $34.80 | 2019-2024 | Paragard T 380a |
| Therapeuticsmd, INC. | $32.58 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $30.25 | 2019 | |
| Olympus America INC. | $19.65 | 2023 | Olympus, Endoeye Flex Deflectable Videoscope |
| Merck Sharp & Dohme LLC | $18.03 | 2021 | |
| Octapharma USA, INC. | $17.81 | 2025 | Fibryga |
| Ethicon US, LLC | $17.26 | 2024 | Ethicon, Enseal X1 |
| Allergan, INC. | $16.31 | 2020 | |
| Lilly USA, LLC | $15.98 | 2025 | Zepbound |
| Millicent US INC | $15.62 | 2025 | Intrarosa |
| Lupin INC. | $13.58 | 2019 | |
| Minerva Surgical, INC | $13.32 | 2019 | |
| Davol INC. | $12.97 | 2023 | Arista Ah Flexitip |
| Scynexis, INC. | $11.81 | 2022 | |
| Duchesnay USA Incorporated | $11.25 | 2019 | |
| Evofem Biosciences, INC. | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olson Parrott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.